Beirut, 22 September 2025: As Lebanon prepares for Pink October, the international breast cancer …
Tag:
AstraZeneca
-
-
Lifestyle & Healthslider
Evusheld long-acting antibody combination retains neutralising activity against Omicron variants BA.4 and BA.5, according to new study from University of Oxford
by Karine Ayoubby Karine AyoubFirst in vitro data on new emerging Omicron variants consistent with Evusheld’s neutralisation activity …
-
Lifestyle & Healthslider
AstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19
by Karine Ayoubby Karine AyoubApproval follows CHMP recommendation for use in patients previously vaccinated with AstraZeneca COVID-19 vaccine …
-
Lifestyle & Healthslider
Joint Statement on the Impact of COVID-19 on Immunocompromised Patients
by Karine Ayoubby Karine AyoubGlobal patient groups call on governments and health system leaders to address the unmet …
-
Lifestyle & Healthslider
Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations
by Karine Ayoubby Karine AyoubPre-exposure prophylaxis (prevention) trial reduced risk of symptomatic COVID-19, with no severe disease or …
-
Lifestyle & Healthslider
Evusheld long-acting antibody combination approved in the EU for pre-exposure prophylaxis (prevention) of COVID-19 in a broad population
by Karine Ayoubby Karine AyoubEvusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial, …
-
Lifestyle & Healthslider
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
by Karine Ayoubby Karine AyoubSuccessful proposals will secure fully funded postdoctoral research positions AstraZeneca today launched a global …
-
Lifestyle & Healthslider
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer
by Karine Ayoubby Karine AyoubFirst HER2-low metastatic breast cancer Phase III results for AstraZeneca and Daiichi Sankyo’s Enhertu …
-
Lifestyle & Healthslider
Update on agreement to supply US with additional doses of Evusheld, a long-acting antibody combination
by Karine Ayoubby Karine AyoubEvusheld has emergency use authorisation for pre-exposure prophylaxis (prevention) of COVID-19 AstraZeneca today welcomes …
-
Lifestyle & Healthslider
New AstraZeneca COVID-19 vaccine data further support its use as third dose booster
by Karine Ayoubby Karine AyoubNew data from ongoing trial showed increased antibody response against Beta, Delta, Alpha and …
Newer Posts